e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Pulmonary circulation: basic science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: IL6 mediated proliferative responses in human pulmonary vascular cells (PVCs) are differentially modulated by Iron/Heme/Hemoglobin
L. Ramakrishnan, S. Mumby, C. Meng, S. J. Wort, G. Quinlan (London, United Kingdom)
Source:
Annual Congress 2013 –Pulmonary circulation: basic science
Session:
Pulmonary circulation: basic science
Session type:
Poster Discussion
Number:
5152
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Ramakrishnan, S. Mumby, C. Meng, S. J. Wort, G. Quinlan (London, United Kingdom). LATE-BREAKING ABSTRACT: IL6 mediated proliferative responses in human pulmonary vascular cells (PVCs) are differentially modulated by Iron/Heme/Hemoglobin. Eur Respir J 2013; 42: Suppl. 57, 5152
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
LATE-BREAKING ABSTRACT: TNFalpha mediates ectodomain shedding of BMPR-II: A potential role in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
Source: Eur Respir J 2008; 31: 135-139
Year: 2008
LATE-BREAKING ABSTRACT: KCNK3 dysfunction contributes to the development of pulmonary arterial hypertension – Characterization of Kcnk3 deficient rats
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
LATE-BREAKING ABSTRACT: A novel and translatable cell assay for the study of vascular signalling in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Is pulmonary hypertension associated with a leakage or an activation of endothelial cells?
Source: Eur Respir J 2003; 22: Suppl. 45, 74s
Year: 2003
Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
C-kit+ cell recruitment in remodelled pulmonary arteries of human PAH
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
LATE-BREAKING ABSTRACT: KCa3.1 ion channel-blockade reduces pulmonary fibrotic responses via the inhibition of fibroblast proliferation
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Exercise induced pressure-flow profiles in the lung circulation have different responses in vasodilator responsive and non-responsive subjects with pulmonary hypertension (PH)
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007
MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007
The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept